Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Similar articles for PubMed (Select 23505048)

1.

Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours.

Garnier D, Jabado N, Rak J.

Proteomics. 2013 May;13(10-11):1595-607. doi: 10.1002/pmic.201200360. Epub 2013 Apr 20. Review.

PMID:
23505048
2.

Oncogenic extracellular vesicles in brain tumor progression.

D'Asti E, Garnier D, Lee TH, Montermini L, Meehan B, Rak J.

Front Physiol. 2012 Jul 24;3:294. doi: 10.3389/fphys.2012.00294. eCollection 2012.

3.

Extracellular vesicles in the biology of brain tumour stem cells--Implications for inter-cellular communication, therapy and biomarker development.

Nakano I, Garnier D, Minata M, Rak J.

Semin Cell Dev Biol. 2015 Apr;40:17-26. doi: 10.1016/j.semcdb.2015.02.011. Epub 2015 Feb 23. Review.

PMID:
25721810
4.

Extracellular vesicles: potential applications in cancer diagnosis, prognosis, and epidemiology.

Verma M, Lam TK, Hebert E, Divi RL.

BMC Clin Pathol. 2015 Apr 15;15:6. doi: 10.1186/s12907-015-0005-5. eCollection 2015.

5.

The proteomics of prostate cancer exosomes.

Drake RR, Kislinger T.

Expert Rev Proteomics. 2014 Apr;11(2):167-77. doi: 10.1586/14789450.2014.890894. Epub 2014 Feb 25.

PMID:
24564711
6.

Extracellular vesicles shed by glioma cells: pathogenic role and clinical value.

Chistiakov DA, Chekhonin VP.

Tumour Biol. 2014 Sep;35(9):8425-38. doi: 10.1007/s13277-014-2262-9. Epub 2014 Jun 27. Review.

PMID:
24969563
7.

Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer.

Rak J.

Front Pharmacol. 2013 Mar 6;4:21. doi: 10.3389/fphar.2013.00021. eCollection 2013.

8.

Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state.

Garnier D, Magnus N, Meehan B, Kislinger T, Rak J.

Exp Cell Res. 2013 Oct 15;319(17):2747-57. doi: 10.1016/j.yexcr.2013.08.003. Epub 2013 Aug 13.

PMID:
23954818
9.

Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science.

Hochberg FH, Atai NA, Gonda D, Hughes MS, Mawejje B, Balaj L, Carter RS.

Expert Rev Mol Diagn. 2014 May;14(4):439-52. doi: 10.1586/14737159.2014.905202. Review.

PMID:
24746164
10.

Tumor-derived exosomes and microvesicles in head and neck cancer: implications for tumor biology and biomarker discovery.

Principe S, Hui AB, Bruce J, Sinha A, Liu FF, Kislinger T.

Proteomics. 2013 May;13(10-11):1608-23. doi: 10.1002/pmic.201200533. Review.

PMID:
23505015
11.

The protein interaction network of extracellular vesicles derived from human colorectal cancer cells.

Choi DS, Yang JS, Choi EJ, Jang SC, Park S, Kim OY, Hwang D, Kim KP, Kim YK, Kim S, Gho YS.

J Proteome Res. 2012 Feb 3;11(2):1144-51. doi: 10.1021/pr200842h. Epub 2012 Jan 9.

PMID:
22149170
12.

Emerging technologies in extracellular vesicle-based molecular diagnostics.

Jia S, Zocco D, Samuels ML, Chou MF, Chammas R, Skog J, Zarovni N, Momen-Heravi F, Kuo WP.

Expert Rev Mol Diagn. 2014 Apr;14(3):307-21. doi: 10.1586/14737159.2014.893828. Epub 2014 Feb 27. Review.

PMID:
24575799
13.

Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.

Kucharzewska P, Christianson HC, Welch JE, Svensson KJ, Fredlund E, Ringnér M, Mörgelin M, Bourseau-Guilmain E, Bengzon J, Belting M.

Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7312-7. doi: 10.1073/pnas.1220998110. Epub 2013 Apr 15.

14.

Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.

Wang Q, Wang L, Li D, Deng J, Zhao Z, He S, Zhang Y, Tu Y.

Cancer Epidemiol. 2013 Feb;37(1):79-84. doi: 10.1016/j.canep.2012.08.011. Epub 2012 Sep 21.

PMID:
22999822
15.

Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.

Choi DS, Choi DY, Hong BS, Jang SC, Kim DK, Lee J, Kim YK, Kim KP, Gho YS.

J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.

16.

First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.

Miller IV, Raposo G, Welsch U, Prazeres da Costa O, Thiel U, Lebar M, Maurer M, Bender HU, von Luettichau I, Richter GH, Burdach S, Grunewald TG.

Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.

PMID:
23521563
17.

Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients.

Santiago-Dieppa DR, Steinberg J, Gonda D, Cheung VJ, Carter BS, Chen CC.

Expert Rev Mol Diagn. 2014 Sep;14(7):819-25. doi: 10.1586/14737159.2014.943193. Review.

18.

Neuro-oncologic applications of exosomes, microvesicles, and other nano-sized extracellular particles.

Gonda DD, Akers JC, Kim R, Kalkanis SN, Hochberg FH, Chen CC, Carter BS.

Neurosurgery. 2013 Apr;72(4):501-10. doi: 10.1227/NEU.0b013e3182846e63. Review.

PMID:
23277376
19.

Blood/plasma secretome and microvesicles.

Inal JM, Kosgodage U, Azam S, Stratton D, Antwi-Baffour S, Lange S.

Biochim Biophys Acta. 2013 Nov;1834(11):2317-25. doi: 10.1016/j.bbapap.2013.04.005. Epub 2013 Apr 13. Review.

PMID:
23590876
20.

Proteomics analysis of bladder cancer exosomes.

Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A.

Mol Cell Proteomics. 2010 Jun;9(6):1324-38. doi: 10.1074/mcp.M000063-MCP201. Epub 2010 Mar 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk